Treatment of Sarcopenia in Post-Hip Fracture Patients (0677-032)
NCT00128115
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
83
Enrollment
INDUSTRY
Sponsor class
Conditions
Hip Fracture
Interventions
DRUG:
MK0677
Sponsor
Merck Sharp & Dohme LLC